Clinical Trial

Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B

Name: Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B — clinical trial record (NCT07709520)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A randomized, double-blind, placebo-controlled Phase IIa clinical study to evaluate the safety and efficacy of GST-HG131/GST-HG141 tablets in patients with chronic hepatitis B

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-12.

Trial Details

NCT Number	NCT07709520
Lead Sponsor	Fujian Akeylink Biotechnology Co., Ltd.
Conditions	Chronic Hepatitis B
Enrollment	80 participants
Start Date	2026-07-10
Primary Completion	2026-10-01 (estimated)
Study Completion	2026-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-17